Viragen, Inc. Announces European Multiferon Licensing Agreement

A A

Viragen, Inc. and its majority-owned subsidiary, Viragen International, Inc., announced that a licensing agreement has been completed with Swedish Orphan International AB, granting exclusive marketing rights to Multiferon (multi-subtype, human alpha interferon) for the European Union (excluding previously licensed member states).
BioSpace